Rosetta Genomics Ltd. (OTCPK: ROSG.Q)
Health Care · Biotechnology · IL
$—
— today · — 1Y
Rosetta Genomics Ltd. (OTCPK: ROSG.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $593.00.
trading between 0.00 and 0.00.
Tweenvest scores Rosetta Genomics Ltd. across four factors: quality 17/100, value 51/100, growth 100/100. Its strongest factor is growth.
ROSG.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $593.00
- Revenue (TTM)
- $2.86M
- P/E
- —
- EPS
- -6.41
- Dividend yield
- —
- Beta (5Y)
- 66.82
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.93M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $265.56 | +0.23% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $441.59 | +0.51% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.66 | +0.37% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $549.34 | +0.24% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $828.52 | -0.66% |
| argenx SEENXTBR: ARGX | $65.85B | €864.20 | -4.19% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $139.50 | -3.84% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.